Small Cell Lung Cancer

The AJMC^® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.

Latest News

Patient with lung cancer wearing head scarf | Image credit: Photographee.eu – stock.adobe.com

Trilaciclib May Help Protect Against Chemotherapy Damage in Small Cell Lung Cancer

By Hayden E. Klein

January 22nd 2025

Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which authors say minimizes the need for supportive care.

Hands holding pack of cigarettes | Image credit: Nopphon – stock.adobe.com

FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases

By Hayden E. Klein

January 16th 2025

Patient receiving lung cancer screening results | Image Credit: Nattakorn - stock.adobe.com

Lung Cancer Screening Facilities Least Accessible to American Indian/Alaska Native Patients, Rural Communities

By Brooke McCormick

January 13th 2025

Heather Wakelee, MD

Considerations for Immunotherapy Duration in NSCLC: Dr Heather Wakelee

September 11th 2024

Diverse representation in health care materials is one of multiple factors that could benefit patient education initiatives | image credit: Fitry - stock.adobe.come

Different Options for Different People: Dr Bellinda King-Kallimanis Explores the State of Patient Education in Lung Cancer

September 10th 2024

Multidisciplinary Approaches to Paraneoplastic LEMS

Hear from medical experts as they explore the connection between Lambert-Eaton myasthenic syndrome and small cell lung cancer, discussing diagnostic challenges, economic impacts, and strategies for optimizing care.

Hear from medical experts as they explore the connection between Lambert-Eaton myasthenic syndrome and small cell lung cancer, discussing diagnostic challenges, economic impacts, and strategies for optimizing care.

More News

OneOncology’s Arrowsmith Looks Forward to Real-time Dynamics in Clinical Pathways

April 14th 2022

OneOncology’s Arrowsmith Looks Forward to Real-time Dynamics in Clinical Pathways

Across OneOncology, says Edward Arrowsmith MD, MPH, clinical pathways offer a vehicle for physicians to agree on best practices and to implement them across the network. Early this year, Arrowsmith became medical director for Clinical Pathways, OneOncology.

scale

April 11th 2022

Excess Body Fat Linked With Increased Risk of Radiation Pneumonitis in NSCLC

Findings suggest measuring excess weight in patients may help predict the development of radiation pneumonitis.

smoke in lungs

April 6th 2022

Real-world Data Show Benefits of Increased Lung Cancer Screening but Persistent Disparities

Although the widespread use of low dose computed tomography screening for lung cancer has led to improved mortality in recent years, disparities in uptake persist throughout the United States.

Melissa Johnson, MD

April 4th 2022

Dr Melissa Johnson Underscores the Need for Lung Cancer Screening Guidance for Never-Smokers

Matthew Gavidia Gianna Melillo

Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, discusses the need for increased lung cancer screening among patients who have no tobacco use history.

Melissa Johnson, MD

April 1st 2022

Dr Melissa Johnson on Addressing Diversity in Cancer Clinical Trials

Gianna Melillo Matthew Gavidia

Melissa Johnson, MD, program director of lung cancer research at Sarah Cannon Research Institute, outlines the importance of diverse patient populations in cancer trials.

pill graphic

March 28th 2022

Study Estimates Impact of Targeted Treatments in NSCLC

Researchers reviewed clinical trial data of 19 FDA-approved treatments for non-small cell lung cancer.

Melissa Johnson MD

March 25th 2022

Dr Melissa Johnson Discusses Barriers to NGS Testing in Lung Cancer

Gianna Melillo Matthew Gavidia

Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, explains factors inhibiting uptake of next-generation sequencing testing among patients with lung cancer.

operating room

March 22nd 2022

Assessing the Rate of Postoperative VTE Among Patients With Stage IA NSCLC

Researchers assessed the incidence of this potentially deadly complication among patients who recently underwent surgery for their non-small cell lung cancer (NSCLC).

lungs

March 18th 2022

Examining the Potential of CAR-T Cell Therapy in Lung Cancer

Authors outlined advancements in chimeric antigen receptor-modified T (CAR-T) cell therapy for lung cancer, and accompanying challenges.

pills and syringe

March 15th 2022

Adding Antiangiogenics to Second-Line Treatment in NSCLC Could Improve Survival

Findings of a meta-analysis suggest adding antiangiogenics to second-line treatment in non–small cell lung cancer (NSCLC) may improve survival outcomes, especially in younger patients.

liver graphic

March 9th 2022

Tool May Enable Prognosis Prediction in Patients With NSCLC, Liver Metastases

Researchers used data to develop a nomogram that identified factors associated with worse prognoses in patients with non–small cell lung cancer (NSCLC) and liver metastases.

lung graphic

March 7th 2022

Review Outlines Barriers to Widespread LDCT Lung Cancer Screening in Europe

Writing in Journal of Internal Medicine, researchers examine potential barriers inhibiting uptake of low-dose CT lung cancer screening in Europe.

lung graphic

March 3rd 2022

Researchers Identify Potential Biomarkers for Combination Treatment Efficacy in NSCLC

A recent study demonstrates certain driver mutations in patients with non–small cell lung cancer (NSCLC) may shorten disease-free survival after combination neoadjuvant immunotherapy and chemotherapy.

DNA strand

February 28th 2022

Analysis Supports Concurrent Plasma NGS, Tissue Testing for NSCLC

Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients.

covid-19 graphic

February 23rd 2022

Study Finds Decline in Global Lung Cancer Clinical Trial Enrollment During COVID-19

Researchers analyzed declines in clinical trial enrollment and asked sites what mitigation strategies they employed to meet the reduction.

money in the sky

February 20th 2022

Drugs Administered In-Hospital Cost Double That of Specialty Pharmacy Rates, AHIP Analysis Finds

Researchers compared drug costs among hospitals, specialty pharmacies, and physician offices.

doctors and patients

February 15th 2022

PRO-Based Symptom Management Improves Postdischarge Outcomes After Lung Cancer Surgery

Patients who utilized a patient-reported outcome (PRO) symptom measurement tool reported superior postdischarge outcomes after lung cancer surgery compared with those who received usual care.

covid-19 graphic

February 13th 2022

Survey Explores Mental Health of Patients With NSCLC During COVID-19

Patients with non–small cell lung cancer (NSCLC) reported superior mental health well-being during the COVID-19 pandemic compared with a control population that did not have cancer.

person smoking

February 11th 2022

CMS Broadens Coverage of Lung Cancer Screening

The national coverage determination will help detect early non-small cell lung cancer, CMS said.

microscope

February 8th 2022

Researchers Identify Potential NSCLC Survival Predictor

Using data from a meta-analysis, researchers determined tumor-stroma ratio could serve as a survival predictor in non–small cell lung cancer (NSCLC).

lungs with smoke

February 4th 2022

LDCT Screening Linked With Overdiagnosis of Lung Cancer Among Taiwanese Women

The overdiagonsis identified in the current study also led to overtreatment in this population, authors found.

pills and syringe

February 2nd 2022

Meta-Analysis Points to Beneficial Role of Dexamethasone Pretreatment in NSCLC

A meta-analysis on first-line treatment for non–small cell lung cancer (NSCLC) in clinical trials revealed that inclusion of dexamethasone along side chemotherapy and PD-L1 inhibitors yielded benefits in this patient population.

money figure

January 25th 2022

Despite New Launches, No Price Drops Seen Among Brand-Name NSCLC Drugs

New research out today details the lack of price reductions seen among recently launched brand-name drugs for non–small cell lung cancer (NSCLC).

lungs with smoke in them

January 24th 2022

Assessing Potential Racial, Ethnic Differences in Lung Cancer Screening in Hawaii

Researchers examined differences in lung cancer screening and follow-up rates among individuals residing in Hawaii.

doctor and patient talking

January 19th 2022

Model Could Help Screen NSCLC Patients Likely to Benefit From Anti–PD-L1 Immunotherapy

A model developed by researchers in China could help identify patients with non–small cell lung cancer (NSCLC) most likely to benefit from anti– programmed death-ligand 1 (PD-L1) immunotherapy.

patient looking out the window

January 17th 2022

Researchers Identify Potential Markers of Chemotherapy Efficacy in NSCLC

Investigators identified potential markers of chemotherapy efficacy in patients with non–small cell lung cancer.

lung graphic

January 13th 2022

Study: USPSTF 2021 Lung Cancer Update Helped Mitigate Screening Racial Disparities

A new analysis published in JAMA Oncology found the United States Preventive Services Task Force's (USPSTF) 2021 update to lung cancer screening recommendations helped close a racial disparity gap in screening rates.

lung image

January 10th 2022

Analysis Details Incidence, Prevalence of NSCLC in the United States

A recent analysis provides updated data on non–small cell lung cancer in the United States.

coins stacked up

January 7th 2022

Study: Cemiplimab More Cost-effective Than Chemotherapy for Some Patients With NSCLC

An analysis concluded that cemiplimab may be more cost-effective than chemotherapy as first-line treatment for some US patients with non–small cell lung cancer (NSCLC).

January 4th 2022

CLN-081 Receives Breakthrough Therapy Designation for NSCLC

Cullinan Oncology’s CLN-081 today received a Breakthrough Therapy Designation from the FDA for the treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC).

...

3 4 5 6 7 8 9 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions